$380,000 of CHUBB INA HOLDINGS INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Various Issues related to the Federal Insurance Office (FIO) and Federal Advisory Committee on Insurance (FACI). Issues related to international capital standards and covered agreements. Issues related to/impacting cyber insurance coverage, ransomware and incident reporting. Issues related to Privacy legislation. Issues related to various Surety & Fidelity Bond requirements. Issues related to risk mitigation and resiliency. Issues related to insurance coverage for various natural catastophes. Issues related to the National Flood Insurance Program (NFIP). Issues related to cannabis safe harbor for insurers. S. 570 / H.R. 1285 - Water Infrastructure Subcontractor and Taxpayer Protection Act. S. 245 - Insure CyberSecurity Act. Issues related to Artificial Intelligence. H.R.643 - Federal Insurance Office Elimination Act S.1544/H.R.3437 - Insurance Data Protection Act Reauthorization of the Cybersecurity Information Sharing Act of 2015 Issues related to international tax proposals. Issues related to third party litigation funding and lawsuit lending. Issues related to U.S. engagement in OECD tax initiatives. Issues related to TCJA extension & various corporate and insurance related tax provisions. S.1821/H.R.3512 - Tackling Predatory Litigation Funding Act. H.R.1 - One Big Beautiful Bill Act Issues related to Mexico's VAT. Issues related to the implementation and review of the U.S.-Mexico-Canada Agreement. Discussions on China-related legislation. Issues related to digital trade, data flows and Artificial Intelligence. Issues related to Sanctions. Issues related to Investment. Issues related to U.S.-Swiss Tax treaty. Issues related to Malaysia divestment requirement. Issues related to U.S. tariffs and trade negotiations. Various issues related to transparency in asbestos bankruptcy trusts. Various tort reform and liability related issues. Issues surrounding arbitration clauses in contracts. Issues related to third party litigation funding and lawsuit lending. S. 706 / H.R. 1530 - Ensuring Justice for Victims of Terrorism Act. H.R. 2675 - Protecting our Courts from Foreign Manipulation Act of 2025."
You can find more data on corporate lobbying on Quiver Quantitative.
CB Congressional Stock Trading
Members of Congress have traded $CB stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CB stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CB Insider Trading Activity
CB insiders have traded $CB stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $CB stock by insiders over the last 6 months:
- JOHN J LUPICA (Vice Chrm, Chubb Group*) has made 0 purchases and 2 sales selling 40,073 shares for an estimated $11,513,506.
- EVAN G GREENBERG (Chairman & CEO) has made 0 purchases and 2 sales selling 29,985 shares for an estimated $9,993,140.
- TIMOTHY ALAN BOROUGHS (Executive Vice President*) has made 0 purchases and 2 sales selling 11,430 shares for an estimated $3,384,390.
- JOSEPH F WAYLAND (Executive Vice President and*) sold 5,830 shares for an estimated $1,731,976
- GEORGE F. OHSIEK (Chief Accounting Officer) has made 0 purchases and 2 sales selling 5,140 shares for an estimated $1,672,698.
- JUAN LUIS ORTEGA (Executive Vice President*) sold 4,357 shares for an estimated $1,285,489
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CB Hedge Fund Activity
We have seen 950 institutional investors add shares of CB stock to their portfolio, and 923 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,049,987 shares (+25.6%) to their portfolio in Q4 2025, for an estimated $951,961,942
- BERKSHIRE HATHAWAY INC added 2,916,288 shares (+9.3%) to their portfolio in Q4 2025, for an estimated $910,231,810
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,548,307 shares (+inf%) to their portfolio in Q4 2025, for an estimated $795,377,580
- GQG PARTNERS LLC added 1,647,729 shares (+15.2%) to their portfolio in Q4 2025, for an estimated $514,289,175
- FMR LLC removed 1,468,730 shares (-11.9%) from their portfolio in Q4 2025, for an estimated $458,420,007
- AQR CAPITAL MANAGEMENT LLC added 1,443,335 shares (+51.6%) to their portfolio in Q4 2025, for an estimated $450,493,720
- VIKING GLOBAL INVESTORS LP added 1,013,839 shares (+inf%) to their portfolio in Q4 2025, for an estimated $316,439,428
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CB Analyst Ratings
Wall Street analysts have issued reports on $CB in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 01/08/2026
- Keefe, Bruyette & Woods issued a "Outperform" rating on 01/06/2026
- JMP Securities issued a "Market Outperform" rating on 10/22/2025
- Evercore ISI Group issued a "Outperform" rating on 10/01/2025
To track analyst ratings and price targets for CB, check out Quiver Quantitative's $CB forecast page.
CB Price Targets
Multiple analysts have issued price targets for $CB recently. We have seen 18 analysts offer price targets for $CB in the last 6 months, with a median target of $337.5.
Here are some recent targets:
- Michael Zaremski from BMO Capital set a target price of $326.0 on 02/10/2026
- Matthew Heimermann from Citigroup set a target price of $385.0 on 02/09/2026
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $373.0 on 02/09/2026
- C. Gregory Peters from Raymond James set a target price of $380.0 on 02/09/2026
- Yaron Kinar from Mizuho set a target price of $336.0 on 02/06/2026
- Elyse Greenspan from Wells Fargo set a target price of $322.0 on 02/05/2026
- David Motemaden from Evercore ISI Group set a target price of $347.0 on 02/04/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
